Preprint / Version 1

Hepato-protective effects and chemical constituents of a bioactive fraction of the traditional compound medicine-Gurigumu-7

Authors

  • Haiyan Xu Collage of Life Science, Inner Mongolia University, Huhhot, Inner Mongolia China
  • Qiong Ma Collage of Life Science, Inner Mongolia University, Huhhot, Inner Mongolia China
  • Jiannan Ma Collage of Life Science, Inner Mongolia University, Huhhot, Inner Mongolia China
  • Zhigang Wu Collage of Life Science, Inner Mongolia University, Huhhot, Inner Mongolia China
  • Yali Wang Collage of Life Science, Inner Mongolia University, Huhhot, Inner Mongolia China
  • Chaomei Ma Collage of Life Science, Inner Mongolia University, Huhhot, Inner Mongolia China

Keywords:

Gurigumu-7, Hepatoprotective effect, Bioactive fraction, Bioactive constituents

Abstract

Gurigumu-7 is an important traditional Mongolian medicine frequently used for liver diseases. However, the pharmacological effects and the bioactive constituents are not well understood. Method This research was to use CCl4-induced liver damage in mice to investigate the hepatoprotective effects of Gurigumu-7 and the methanol eluted fraction from a DIAION column of an extract of Gurigumu-7 (MF). The chemical constituents of MF were analyzed by UPLC-MS. Results Pretreated orally with MF (66, 132 and 264 mg/kg) once a day for 4 days dose-dependently suppressed CCl4-induced mice liver histopathological changes and serum aminotransferase activities (alanine transaminase: 1144.0 ± 787.2 v.s. 2461.8 ± 1072.7 U/L, p < 0.05; aspartate transaminase: 1173 ± 785.3 v.s. 2506.6 ± 1140.7 U/L, p < 0.01). MF treated group demonstrated increased levels of SOD (108.19 ± 30.32 v.s. 75.75 ± 5.37 U/mg protein, p < 0.01) but decreased levels of malonyldialdehyde (7.68 ± 1.95 v.s. 44.32 ± 16.68 nmol/mg protein, p < 0.01) compared to the CCl4 control group. More than 30 chemical constituents were quantified, and MF was found to be rich in ellagic acid (297.97 mg/g), luteolin and its glucosides (35.10 mg/g), apigenin and its glucosides (>30 mg/g), ursolic acid (14.91 mg/g), bidenoside C (8.75 mg/g), and proanthocyanidins (15.64 mg/g in proanthocyanidin A2 equivalent). Conclusion The methanol eluted fraction (MF) from a DIAION column of an extract of the Mongolian medicine-Gurigumu-7 was found to be more hepatoprotective than Gurigumu-7. The results suggested that MF is a promising bioactive fraction for the development of new hepatoprotective medicine with better formulation and quality control properties. Keywords: Gurigumu-7, Hepatoprotective effect, Bioactive fraction, Bioactive constituents

Downloads